0: Serum and urine samples were collected from patients that were diagnosed with lung adenocarcinoma at the General Hospital of the Chinese People's Liberation Army from June 2017 to June 2018.
1: The discovery set consisted of 30 healthy individuals and 70 lung adenocarcinoma patients at early stages (stage Ia1,  n = 10; stage Ia2,  n = 10; stage Ia3,  n = 10; stage Ib,  n = 10; and stage II,  n = 10) and late stages (stage III,  n = 10; stage IV,  n = 10).
2: Healthy controls were age- and gender-matched to the lung adenocarcinoma patients ( Table 1).
3: Of note, serum and urine samples were collected before the 70 lung adenocarcinoma patients had undergone chemical or medical treatment.
4: All samples were collected from patients with an empty stomach in the morning.
5: All participants provided signed informed consent, and samples were collected following the protocol approval.
6: All methods were carried out in accordance with the approved guidelines, and all experimental protocols were approved by the ethics committee of the Chinese PLA General Hospital (Number S2018-007-001).
7: Each serum sample was allowed to clot for 45 min and then centrifuged at 2,000 rpm for 10 min.
8: For urine samples, a morning midstream urine specimen was collected and centrifuged at 1,500 rpm for 5 min.
9: All samples were aliquoted and stored at 80C until use.
